7-methyl-7,8-dihydro-6-thio-guanosine

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: 7-methyl-7,8-dihydro-6-thio-guanosine
• 英文别名: 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-3,8-dihydropurine-6-thione
• 化学式: C₁₁H₁₇N₅O₄S
• 分子量: 315.353
• InChiKey: VAXBEGYAFJOXBG-KQYNXXCUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.7
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  159
• 氢给体数：
  5
• 氢受体数：
  7

文献信息

• Gyrase inhibitors
  申请人：Yager Kraig

  公开号：US20050054697A1

  公开（公告）日：2005-03-10

  Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.

  含有吲唑基团和噻唑基团的化合物，优选为7-取代的3-(噻唑-2-基)-1H-吲唑化合物，其中吲唑基团和噻唑基团各自可选择性地被取代，适用于治疗或预防哺乳动物的细菌感染。据信这些化合物通过抑制酶A来发挥作用。
• OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS
  申请人：BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY

  公开号：US20180271098A1

  公开（公告）日：2018-09-27

  Antimicrobial resistance is rising at an alarming rate. The methylerythritol phosphate (MEP) pathway is a metabolic pathway that produces the isoprenoids isopentyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). Notably, the MEP pathway is present in bacteria and not mammals, which made the enzymes of the MEP pathway attractive targets for discovering new anti-infective agents due to reduced chances of off-target interactions leading to side effects. The biophysical properties of 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (IspD) and 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) were determined to aid discovery of novel inhibitors. Thermal shift screening was used as an initial filter to narrow down a library of compounds with thermal shifts greater than 1° C., which could indicate binding to the IspD and IspE enzymes. Follow-up studies were performed using isothermal titration calorimetry and enzymatic inhibition assays. Results from these studies have revealed compounds with high micromolar inhibition of both IspD from Escherichia coli and IspE from Burkholderia thailandensis . The hit compounds are used for future development of more potent IspD and IspE inhibitors.

  抗微生物药物耐药性正在以令人担忧的速度上升。 甲基赤霉酸磷酸(MEP)途径是一种产生异戊二烯醇磷酸丙酯（IPP）和二甲基磷酸丙酯（DMAPP）的代谢途径。 值得注意的是，MEP途径存在于细菌中而不在哺乳动物中，这使得MEP途径的酶成为发现新抗感染剂的有吸引力的靶点，因为减少了产生副作用的离靶相互作用的机会。 通过测定2-C-甲基-D-赤霉酸4-磷酸胞苷基转移酶（IspD）和4-二磷酸胞苷基-2-C-甲基-D-赤霉酸激酶（IspE）的生物物理特性，有助于发现新的抑制剂。 利用热位移筛选作为初始过滤器，缩小了具有大于1°C热位移的化合物库，这可能表明这些化合物与IspD和IspE酶结合。 随后使用等温滴定热量计和酶抑制测定进行了后续研究。 这些研究结果显示出对大肠杆菌IspD和泰国布氏杆菌IspE均具有高微摩尔抑制作用的化合物。 这些有效化合物将用于未来开发更有效的IspD和IspE抑制剂。
• [EN] NEW METHIONINE METABOLIC PATHWAY INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE LA VOIE MÉTABOLIQUE DE MÉTHIONINE
  申请人：GAVISH GALILEE BIO APPL LTD

  公开号：WO2019142192A1

  公开（公告）日：2019-07-25

  Novel compounds capable of inhibiting methionine metabolic pathway are provided. These compounds are used in inhibiting cystathionin γ-synthase (CGS) in general, and in plants, fungi and bacteria, in particular. These compounds of the invention are used as herbicides, pesticides, fungicides, agricultural plant stimulants or antimicrobial agents. The compounds of the present invention can be used for seed treatment. In particular, the compounds of the invention are used as selective herbicides, non-selective herbicides, agricultural herbicides, non-agricultural herbicides or weed killers, herbicides in integrated pest management, herbicides in gardening, herbicides in clearing waste ground, herbicides in clearing industrial or constructions sites, or herbicides in clearing railways and railway embankments.

  本发明提供了一种能够抑制蛋氨酸代谢途径的新化合物。这些化合物通常用于抑制半胱氨酸γ-合成酶（CGS），尤其是在植物、真菌和细菌中。本发明的这些化合物可用作除草剂、杀虫剂、杀菌剂、农业植物刺激剂或抗微生物剂。本发明的化合物可用于种子处理。特别地，本发明的化合物可用作选择性除草剂、非选择性除草剂、农业除草剂、非农业除草剂或除草剂、综合害虫管理中的除草剂、园艺中的除草剂、清理废地中的除草剂、清理工业或建筑工地中的除草剂，或清理铁路和铁路路基中的除草剂。
• Therapeutic Agent For Solid Tumor
  申请人：Murakata Chikara

  公开号：US20080194653A1

  公开（公告）日：2008-08-14

  A therapeutic and/or prophylactic agent for a solid tumor, which comprises a thiadiazoline derivative represented by the general formula (I), or a pharmaceutically acceptable salt thereof: [wherein, n represents an integer of 1 to 3, R 1 represents a hydrogen atom, R 2 represents lower alkyl, or R 1 and R 2 are combined together to represent alkylene, R 3 represents lower alkyl, R 4 represents NHSO 2 R 6 (wherein R 6 represents hydroxy or the like) or the like, and R 5 represents aryl or the like] and the like are provided.

  本发明提供了一种治疗和/或预防实体肿瘤的治疗剂和/或预防剂，其包括由通式（I）表示的噻二唑啉衍生物或其药学上可接受的盐：[其中，n表示1至3的整数，R1表示氢原子，R2表示较低的烷基，或R1和R2结合在一起表示烷基，R3表示较低的烷基，R4表示NHSO2R6（其中R6表示羟基或类似物）或类似物，R5表示芳基或类似物]。
• Thiadiazoline derivative
  申请人：Murakata Chikara

  公开号：US20070112044A1

  公开（公告）日：2007-05-17

  An antitumor agent comprising a thiadiazoline derivative represented by the general formula (I), or a pharmacologically acceptable salt thereof as an active ingredient: (wherein Z represents a sulfur atom and the like, R 1 represents substituted or unsubstituted lower alkynyl and the like, R 2 represents a hydrogen atom and the like, R 3 represents substituted or unsubstituted lower alkyl and the like, and R 4 represents substituted or unsubstituted aryl and the like), and the like are provided.

  一种抗肿瘤剂，包括由通式（I）表示的噻二唑衍生物或其药学上可接受的盐作为活性成分：（其中Z代表硫原子等，R1代表取代或未取代的较低炔基等，R2代表氢原子等，R3代表取代或未取代的较低烷基等，R4代表取代或未取代的芳基等）等。